세계의 장시간 작용형 피임약 시장 : 유형, 제품, 용도, 최종 용도별 예측(2025-2030년)

The Long-acting Contraception Market was valued at USD 3.42 billion in 2023, expected to reach USD 3.68 billion in 2024, and is projected to grow at a CAGR of 7.06%, to USD 5.52 billion by 2030.

Long-acting contraception encompasses devices and medications designed to prevent pregnancy over an extended period, such as intrauterine devices (IUDs) and hormonal implants. Their necessity is underscored by their ability to provide reliable birth control options with minimal user intervention, addressing unmet needs for effective family planning, especially in regions with limited access to healthcare. Applications are widespread among women seeking convenient contraceptive solutions without daily adherence issues. The end-use scope is diverse, including healthcare establishments, government family planning initiatives, and non-profit organizations aiming to enhance reproductive health. Market growth is propelled by a rising global focus on women's health, increased awareness and acceptance of long-acting methods, and government initiatives supporting family planning. Technological advancements in product design, leading to fewer side effects and improved efficacy, are also pivotal. Opportunities abound in emerging markets due to growing healthcare infrastructure and shifting societal attitudes towards reproductive health. Companies should leverage partnerships with local governments for awareness campaigns and collaborate on subsidized programs to penetrate these regions effectively. However, barriers persist, such as cultural and religious reservations, lack of trained healthcare providers, and high initial costs for some end-users, which may stall market adoption. Regulatory challenges and misconceptions about side effects further complicate market dynamics. To drive innovation, businesses should focus on developing more user-friendly, reversible, and cost-effective methods, with an emphasis on reducing adverse effects. Improved healthcare provider training and patient education programs can mitigate misconceptions, fostering market expansion. Understanding the nature of this market involves acknowledging its sensitivity due to sociopolitical factors but also recognizing its potential for transformative growth through targeted outreach and technological enhancement. Aligning business strategies with local healthcare policies and enhancing awareness about long-acting contraceptive benefits can drive substantial market share gains.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Long-acting Contraception Market

The Long-acting Contraception Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising adoption of long term contraception among male and female
  • Rising publicly funded family planning services
• Market Restraints
  • Associated side effects of long term contraception
• Market Opportunities
  • Introduction of technically advanced long term contraception methods
  • Strong government support for LTC
• Market Challenges
  • Concern regarding limited approved products

Porter's Five Forces: A Strategic Tool for Navigating the Long-acting Contraception Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Long-acting Contraception Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Long-acting Contraception Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Long-acting Contraception Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Long-acting Contraception Market

A detailed market share analysis in the Long-acting Contraception Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Long-acting Contraception Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Long-acting Contraception Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Long-acting Contraception Market

A strategic analysis of the Long-acting Contraception Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Long-acting Contraception Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayer AG, DKT International, HRA Pharma SAS by Perrigo Company plc, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., OCON Healthcare, Pfizer Inc., Pregna International Limited, Prosan International B.V., SMB Corporation of India, Teva Pharmaceuticals Industries Ltd., The Cooper Companies, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Long-acting Contraception Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Long-Acting Contraceptives and Short-Acting Contraceptives.
• Based on Product, market is studied across Injectables, Intrauterine Devices, and Subdermal Implants.
• Based on Application, market is studied across Contraception, HIV, and Schizophrenia.
• Based on End-use, market is studied across Drug Store, E-Commerce, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising adoption of long term contraception among male and female
    • 5.1.1.2. Rising publicly funded family planning services
  • 5.1.2. Restraints
    • 5.1.2.1. Associated side effects of long term contraception
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of technically advanced long term contraception methods
    • 5.1.3.2. Strong government support for LTC
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding limited approved products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Long-acting Contraception Market, by Type

• 6.1. Introduction
• 6.2. Long-Acting Contraceptives
• 6.3. Short-Acting Contraceptives

7. Long-acting Contraception Market, by Product

• 7.1. Introduction
• 7.2. Injectables
• 7.3. Intrauterine Devices
• 7.4. Subdermal Implants

8. Long-acting Contraception Market, by Application

• 8.1. Introduction
• 8.2. Contraception
• 8.3. HIV
• 8.4. Schizophrenia

9. Long-acting Contraception Market, by End-use

• 9.1. Introduction
• 9.2. Drug Store
• 9.3. E-Commerce
• 9.4. Hospital

10. Americas Long-acting Contraception Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Long-acting Contraception Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Long-acting Contraception Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Bayer AG
• 3. DKT International
• 4. HRA Pharma SAS by Perrigo Company plc
• 5. Merck & Co., Inc.
• 6. Meril Life Sciences Pvt. Ltd.
• 7. Mona Lisa N.V.
• 8. OCON Healthcare
• 9. Pfizer Inc.
• 10. Pregna International Limited
• 11. Prosan International B.V.
• 12. SMB Corporation of India
• 13. Teva Pharmaceuticals Industries Ltd.
• 14. The Cooper Companies, Inc.
• 15. Viatris Inc.